The „Hopp Children's Cancer Center Heidelberg” (KiTZ) is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital (UKHD) and the Heidelberg University (UniHD). As a therapy and research center for oncologic and hematologic diseases in children and adolescents, the KiTZ is committed to scientifically exploring the biology of childhood cancer and to closely linking promising research approaches with patient care – from diagnosis to treatment and aftercare.
Children suffering from cancer, especially those with no established therapy options, are given an individual therapy plan in the KiTZ, which is created by interdisciplinary expert groups in so-called tumor boards. Many young patients can participate in clinical trials which ensures access to new therapy options. Thus, the KiTZ is a pioneering institution for transferring research knowledge from the laboratory to the clinic.
The Department of Paediatric Oncology, Haematology and Immunology at the University Hospital Heidelberg and the Hopp-Kindertumorzentrum Heidelberg has been awarded as "Certified Pediatric Oncology Centre" by the German Cancer Society (DKG). This award proves that the clinic meets the high quality requirements of pediatric oncology centres according to the requirements of the German Cancer Society.